October 28, 2016 1:54 PM ET

Capital Markets

Company Overview of Frazier Healthcare Partners

Company Overview

Frazier Healthcare Partners is a private equity and venture capital firm specializing in growth equity financing; incubation; expansion stage equity; recapitalizations; corporate divestitures, and carve-outs; leveraged recapitalizations; growth buyouts; spinouts; shareholder liquidity; startups, early stage investments including seed and Series A and B finan unmet medical needs cing rounds; late stage investments including Series C, D, mid venture, middle market, bridge financing, and PIPEs investments; and de novo investments across all stages of a company’s development. Within Life Science, it prefers to invest in drug development ranging from early-stage, pre-clinical opportunities, to la...

Two Union Square

601 Union Street

Suite 3200

Seattle, WA 98101

United States

Founded in 1991





Key Executives for Frazier Healthcare Partners

Founder, Managing Partner, Senior Advisor, and Chairman
Age: 65
Chief Financial Officer and Partner
General Partner, Managing General Partner, Founding General Partner, and Member of Management Committee
Age: 50
Managing General Partner
Age: 46
Compensation as of Fiscal Year 2016.

Frazier Healthcare Partners Key Developments

Frazier Healthcare Partners Appoints Brock Hardaway as an Operating Partner

Frazier Healthcare Partners announced that Brock Hardaway has joined the firm as an Operating Partner on the Growth Buyout team. He will assist the Growth Buyout team with identifying and executing opportunities in the post-acute sector. Brock most recently served as CEO of Millennium Health. In addition to clinical toxicology and under his leadership, the company developed a suite of genetic testing and predictive analytic products that armed healthcare providers with medication intelligence in an effort to improve medication effectiveness. Brock has also spent more than 23 years in various leadership and senior executive roles in the post-acute sector.

Frazier Healthcare Seeks Acquisitions

Frazier Healthcare Partners will comsider acquisitions. Frazier Healthcare has a $525 million health care buyout fund, which it closed in March 2016, and it is looking to buy companies with potential for fast earnings growth, increase those earnings and then sell the company or take it public.

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced the formation of Outpost Medicine, a biopharmaceutical company focused on the development of new treatments of urologic and gynecologic diseases and disorders. In exchange for undisclosed financial terms, Takeda has granted an exclusive license to Outpost for the worldwide development and commercialization rights to OP-233 (formerly TAK-233), a clinical-stage product candidate being studied for the treatment of stress urinary incontinence. In connection with the license, Outpost has completed a $41 million financing led by Frazier Healthcare Partners and including Adams Street Partners, Novo A/S, and Vivo Capital. Joining Tachi Yamada and David Socks on the Outpost board of directors are Dan Estes, Ph.D., Principal of Frazier Healthcare Partners, Terry Gould, Partner and Head of Direct Investments of Adams Street Partners, Peter Bisgaard, Senior Partner of Novo Ventures (US) Inc., and Chen Yu, M.D., Managing Partner of Vivo Capital.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

September 20, 2016
Tobira Therapeutics, Inc.
Private Placement
August 28, 2016
CCHN Group Holdings, Inc.
August 15, 2016
Semnur Pharmaceuticals, Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Frazier Healthcare Partners, please visit www.frazierhealthcare.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.